FilingSEC EDGAR8-K
ABVC BioPharma completes separation and distribution of BioKey subsidiary.
· SEC accepted
StageCompleted
Filing content
The company completed the separation of BioKey and distributed 15% of its ordinary shares to ABVC shareholders as of August 21.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…